New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Dyadic International Inc. (DYAI) vs Fractyl Health, Inc. (GUTS)
- Dyadic International Inc. DYAI 0.29 −6.45%
- Fractyl Health, Inc. GUTS 0.82 −14.58%
Dyadic International Inc. and Fractyl Health, Inc. are both Biotechnology companies. Dyadic International Inc. and Fractyl Health, Inc. are of similar size ($12.7M and $12.5M). Dyadic International Inc. grew revenue faster over the last twelve months: −7.64% against −22.5%. Dyadic International Inc. has the higher net margin (−226.9% vs −75,732.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Dyadic International Inc. leads on 10 and Fractyl Health, Inc. on 5.
Valuation
Profitability
| Metric | DYAI | GUTS | Biotechnology median |
|---|---|---|---|
| Gross margin | 17.85% | 46.24% | 70.18% |
| Operating margin | (237.12%) | (100,570.97%) | 0.00% |
| Net margin | (226.87%) | (75,732.26%) | 0.00% |
| Free cash flow margin | (227.93%) | (72,350.54%) | 0.00% |
| Return on equity | (47,316.89%) | 905.17% | (51.58%) |
| Return on assets | (71.43%) | (82.35%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack